Profile
Olivier Meyer is the founder of Carlina Technologies SAS, which was founded in 2010.
He held the title of President & Chief Executive Officer at Carlina Technologies SAS. Dr. Meyer's former jobs include President & Chief Executive Officer at Bioxel Pharma, Inc., Assistant Director at AstraZeneca SAS, and Head-Laboratory at Transgene SA. Dr. Meyer received a doctorate degree from Université de Paris XI Paris Sud in 1995.
Former positions of Olivier Meyer
| Companies | Position | End |
|---|---|---|
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and commercializes pharmaceutical products | Corporate Officer/Principal | - |
Carlina Technologies SAS
Carlina Technologies SAS BiotechnologyHealth Technology Develops micro and nanomedicines | Chief Executive Officer | - |
| TRANSGENE | Corporate Officer/Principal | - |
Bioxel Pharma, Inc.
Bioxel Pharma, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Chief Executive Officer | - |
Training of Olivier Meyer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Bioxel Pharma, Inc.
Bioxel Pharma, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Université de Paris XI Paris Sud
Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and commercializes pharmaceutical products | Health Technology |
Carlina Technologies SAS
Carlina Technologies SAS BiotechnologyHealth Technology Develops micro and nanomedicines | Health Technology |
- Stock Market
- Insiders
- Olivier Meyer
















